Recently, the research team led by Professor Zhang Zhongtao and Professor Yao Hongwei from the General Surgery Center at Beijing Friendship Hospital, Capital Medical University, published a review ...

Pat Gulhati, MD, PhD, discusses findings from a comprehensive analysis of genetic, immunological, and signaling pathway variations in pancreatic cancer.

In recent years, cancer immunotherapy, exemplified by PD-1 and its ligand PD-L1 blockade ... involved in the regulation of immune cells signaling pathways that promote tumorigenesis by attenuating ...